Jan 15, 2013 by Brenton FlynnWhat Color Is Your Patent Cliff Parachute?What happens to the new AbbVie when Humira hits the patent cliff?
Jan 15, 2013 by Brenton FlynnThese Buyouts Were Anything But GivenGiven Imaging slides on abandoned buyout hopes.
Jan 15, 2013 by Brenton FlynnSantarus Soars on FDA ApprovalSantarus continues to soar past investor expectations.
Jan 14, 2013 by Brenton FlynnAnother Potential Blockbuster for Johnson & Johnson InvestorsBig news for Johnson and Johnson's diabetes drug.
Jan 14, 2013 by Brenton Flynn3 Things to Watch at Eli LillyThree things for Eli Lilly investors to focus on.
Jan 14, 2013 by Brenton FlynnPharma's BRIC BuildingThe BRIC countries are considered a big area of future growth for pharma.
Jan 14, 2013 by Brenton FlynnHow Big Can This Blockbuster Drug Get?Just how far can AbbVie push its number 1 moneymaker?
Jan 13, 2013 by Brenton FlynnWill Pharma Fix Health Care?Is there a fix for soaring health-care costs?
Jan 12, 2013 by Brenton FlynnThe Battle for Diabetes DominanceNearly every Big Pharma company is looking for a slice of the diabetes market.
Jan 11, 2013 by Brenton FlynnIs Medivation Too Expensive?Is all of the upside already baked into Medivation?
Jan 11, 2013 by Brenton Flynn3 Catalysts for MedivationHere are 3 key things that could drive Medivation shares.
Jan 11, 2013 by Brenton FlynnThe Biggest Week in Health CareFour major themes from the year's biggest healthcare conference.
Jan 10, 2013 by Brenton FlynnThe Most Neglected Big Biotech1 biotech that hasn't been receiving much attention lately
Jan 9, 2013 by Brenton FlynnThe New Abbott's First WordsThe new Abbott Labs, minus AbbVie, speaks for the first time.
Jan 8, 2013 by Brenton Flynn3 Bearish Points Against This BiotechA bear's take on the Dendreon conference presentation.
Jan 8, 2013 by Brenton FlynnThe Biggest Tailwind in Catamaran's SailsThis pharmacy benefit management company's relatively small size can be a big asset.
Jan 8, 2013 by Brenton FlynnA Coming Boom for EHR StocksThe explosion is on the way for this struggling health-care industry.
Jan 8, 2013 by Brenton FlynnRough Waters Ahead for Pharmacy Benefit Management Companies?Is the PBM industry headed for tough times?
